Treatment for depression could be revolutionised with new and more effective drug options thanks to a breakthrough involving ...

Scientists have identified new genetic risk factors for depression across all major global populations after a study involving five million participants, giving hope for new treatments. The world’s ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

An international team of researchers has found hundreds of new genetic variants linked to depression, which has the potential ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

We’re used to hearing that depression is a chemical problem, one that starts in the brain and can only be fixed with ...